Islay Capital Management LLC Purchases Shares of 3,150 Molina Healthcare, Inc $MOH

Key Points

• Islay Capital Management LLC acquired a new stake in Molina Healthcare, purchasing 3,150 shares valued at approximately $1,038,000.
• Molina Healthcare reported a 15.7% year-over-year increase in quarterly revenue, totaling $11.43 billion, despite missing EPS estimates.
• Brokerages have issued downgrades on Molina Healthcare's stock, with Morgan Stanley reducing their price target from $364 to $266, indicating a shift in market perception.

Islay Capital Management LLC bought a new position in Molina Healthcare, Inc (NYSE:MOH - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 3,150 shares of the company's stock, valued at approximately $1,038,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of MOH. Teacher Retirement System of Texas bought a new position in Molina Healthcare in the 1st quarter worth $2,759,000. Farther Finance Advisors LLC increased its stake in shares of Molina Healthcare by 100.3% during the first quarter. Farther Finance Advisors LLC now owns 659 shares of the company's stock valued at $216,000 after purchasing an additional 330 shares in the last quarter. Robeco Institutional Asset Management B.V. purchased a new position in Molina Healthcare during the first quarter valued at $1,070,000. Wealth Enhancement Advisory Services LLC boosted its stake in Molina Healthcare by 82.1% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 15,635 shares of the company's stock worth $5,150,000 after purchasing an additional 7,051 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC bought a new position in shares of Molina Healthcare in the first quarter worth approximately $255,000. Institutional investors own 98.50% of the company's stock.

Insider Transactions at Molina Healthcare

In other news, COO James Woys bought 10,000 shares of the stock in a transaction on Monday, August 4th. The stock was bought at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the purchase, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. The trade was a 15.54% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ronna Romney sold 700 shares of Molina Healthcare stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Wall Street Analyst Weigh In

MOH has been the topic of a number of research analyst reports. UBS Group lowered their price target on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Robert W. Baird reduced their price objective on Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Wells Fargo & Company decreased their target price on shares of Molina Healthcare from $216.00 to $198.00 and set an "overweight" rating on the stock in a research note on Friday, August 15th. Morgan Stanley downgraded Molina Healthcare from an "overweight" rating to an "equal weight" rating and lowered their price objective for the company from $364.00 to $266.00 in a research report on Thursday, July 10th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a research report on Tuesday, July 29th. Three equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, Molina Healthcare presently has an average rating of "Hold" and a consensus target price of $242.91.

Molina Healthcare Trading Up 3.5%

Shares of NYSE MOH traded up $6.15 during trading hours on Friday, reaching $180.87. The stock had a trading volume of 1,442,841 shares, compared to its average volume of 1,007,705. Molina Healthcare, Inc has a 52-week low of $151.95 and a 52-week high of $365.23. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77. The business's fifty day moving average price is $201.59 and its two-hundred day moving average price is $273.82. The firm has a market cap of $9.80 billion, a price-to-earnings ratio of 8.91 and a beta of 0.52.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The business had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The firm's revenue was up 15.7% compared to the same quarter last year. During the same period last year, the company earned $5.86 earnings per share. Analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.